<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d78" origId="Esmolol"><sentence id="DrugDDI.d78.s0" origId="s0" text="Catecholamine-depleting drugs, e.g., reserpine, may have an additive effect when given with beta blocking agents."><entity id="DrugDDI.d78.s0.e0" origId="s0.p0" charOffset="24-29" type="drug" text="drugs"/><entity id="DrugDDI.d78.s0.e1" origId="s0.p3" charOffset="37-46" type="drug" text="reserpine"/><entity id="DrugDDI.d78.s0.e2" origId="s0.p9" charOffset="92-112" type="drug" text="beta blocking agents"/><pair id="DrugDDI.d78.s0.p0" e1="DrugDDI.d78.s0.e0" e2="DrugDDI.d78.s0.e1" interaction="false"/><pair id="DrugDDI.d78.s0.p1" e1="DrugDDI.d78.s0.e0" e2="DrugDDI.d78.s0.e2" interaction="true"/><pair id="DrugDDI.d78.s0.p2" e1="DrugDDI.d78.s0.e1" e2="DrugDDI.d78.s0.e2" interaction="true"/></sentence><sentence id="DrugDDI.d78.s1" origId="s1" text="Patients treated concurrently with BREVIBLOC (esmolol HCl) and a catecholamine depletor should therefore be closely observed for evidence of hypotension or marked bradycardia, which may result in vertigo, syncope, or postural hypotension."><entity id="DrugDDI.d78.s1.e0" origId="s1.p13" charOffset="35-44" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s1.e1" origId="s1.p15" charOffset="46-57" type="drug" text="esmolol HCl"/><pair id="DrugDDI.d78.s1.p0" e1="DrugDDI.d78.s1.e0" e2="DrugDDI.d78.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d78.s2" origId="s2" text="A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels."><entity id="DrugDDI.d78.s2.e0" origId="s2.p37" charOffset="31-40" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s2.e1" origId="s2.p39" charOffset="45-53" type="drug" text="warfarin"/><entity id="DrugDDI.d78.s2.e2" origId="s2.p42" charOffset="96-105" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s2.e3" origId="s2.p44" charOffset="110-118" type="drug" text="warfarin"/><entity id="DrugDDI.d78.s2.e4" origId="s2.p48" charOffset="134-142" type="drug" text="warfarin"/><pair id="DrugDDI.d78.s2.p0" e1="DrugDDI.d78.s2.e0" e2="DrugDDI.d78.s2.e1" interaction="false"/><pair id="DrugDDI.d78.s2.p1" e1="DrugDDI.d78.s2.e0" e2="DrugDDI.d78.s2.e2" interaction="false"/><pair id="DrugDDI.d78.s2.p2" e1="DrugDDI.d78.s2.e0" e2="DrugDDI.d78.s2.e3" interaction="false"/><pair id="DrugDDI.d78.s2.p3" e1="DrugDDI.d78.s2.e0" e2="DrugDDI.d78.s2.e4" interaction="false"/><pair id="DrugDDI.d78.s2.p4" e1="DrugDDI.d78.s2.e1" e2="DrugDDI.d78.s2.e2" interaction="false"/><pair id="DrugDDI.d78.s2.p5" e1="DrugDDI.d78.s2.e1" e2="DrugDDI.d78.s2.e3" interaction="false"/><pair id="DrugDDI.d78.s2.p6" e1="DrugDDI.d78.s2.e1" e2="DrugDDI.d78.s2.e4" interaction="false"/><pair id="DrugDDI.d78.s2.p7" e1="DrugDDI.d78.s2.e2" e2="DrugDDI.d78.s2.e3" interaction="false"/><pair id="DrugDDI.d78.s2.p8" e1="DrugDDI.d78.s2.e2" e2="DrugDDI.d78.s2.e4" interaction="false"/><pair id="DrugDDI.d78.s2.p9" e1="DrugDDI.d78.s2.e3" e2="DrugDDI.d78.s2.e4" interaction="false"/></sentence><sentence id="DrugDDI.d78.s3" origId="s3" text="BREVIBLOC concentrations were equivocally higher when given with warfarin, but this is not likely to be clinically important."><entity id="DrugDDI.d78.s3.e0" origId="s3.p49" charOffset="0-9" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s3.e1" origId="s3.p54" charOffset="65-73" type="drug" text="warfarin"/><pair id="DrugDDI.d78.s3.p0" e1="DrugDDI.d78.s3.e0" e2="DrugDDI.d78.s3.e1" interaction="false"/></sentence><sentence id="DrugDDI.d78.s4" origId="s4" text="When digoxin and BREVIBLOC were concomitantly administered intravenously to normal volunteers, there was a 10-20% increase in digoxin blood levels at some time points."><entity id="DrugDDI.d78.s4.e0" origId="s4.p62" charOffset="5-12" type="drug" text="digoxin"/><entity id="DrugDDI.d78.s4.e1" origId="s4.p64" charOffset="17-26" type="drug" text="BREVIBLOC"/><pair id="DrugDDI.d78.s4.p0" e1="DrugDDI.d78.s4.e0" e2="DrugDDI.d78.s4.e1" interaction="true"/></sentence><sentence id="DrugDDI.d78.s5" origId="s5" text="Digoxin did not affect BREVIBLOC pharmacokinetics."><entity id="DrugDDI.d78.s5.e0" origId="s5.p75" charOffset="0-7" type="drug" text="Digoxin"/><entity id="DrugDDI.d78.s5.e1" origId="s5.p79" charOffset="23-32" type="drug" text="BREVIBLOC"/><pair id="DrugDDI.d78.s5.p0" e1="DrugDDI.d78.s5.e0" e2="DrugDDI.d78.s5.e1" interaction="false"/></sentence><sentence id="DrugDDI.d78.s6" origId="s6" text="When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine."><entity id="DrugDDI.d78.s6.e0" origId="s6.p81" charOffset="17-25" type="drug" text="morphine"/><entity id="DrugDDI.d78.s6.e1" origId="s6.p83" charOffset="30-39" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s6.e2" origId="s6.p89" charOffset="105-113" type="drug" text="morphine"/><entity id="DrugDDI.d78.s6.e3" origId="s6.p94" charOffset="141-150" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s6.e4" origId="s6.p99" charOffset="218-226" type="drug" text="morphine"/><pair id="DrugDDI.d78.s6.p0" e1="DrugDDI.d78.s6.e0" e2="DrugDDI.d78.s6.e1" interaction="false"/><pair id="DrugDDI.d78.s6.p1" e1="DrugDDI.d78.s6.e0" e2="DrugDDI.d78.s6.e2" interaction="false"/><pair id="DrugDDI.d78.s6.p2" e1="DrugDDI.d78.s6.e0" e2="DrugDDI.d78.s6.e3" interaction="false"/><pair id="DrugDDI.d78.s6.p3" e1="DrugDDI.d78.s6.e0" e2="DrugDDI.d78.s6.e4" interaction="false"/><pair id="DrugDDI.d78.s6.p4" e1="DrugDDI.d78.s6.e1" e2="DrugDDI.d78.s6.e2" interaction="false"/><pair id="DrugDDI.d78.s6.p5" e1="DrugDDI.d78.s6.e1" e2="DrugDDI.d78.s6.e3" interaction="false"/><pair id="DrugDDI.d78.s6.p6" e1="DrugDDI.d78.s6.e1" e2="DrugDDI.d78.s6.e4" interaction="false"/><pair id="DrugDDI.d78.s6.p7" e1="DrugDDI.d78.s6.e2" e2="DrugDDI.d78.s6.e3" interaction="false"/><pair id="DrugDDI.d78.s6.p8" e1="DrugDDI.d78.s6.e2" e2="DrugDDI.d78.s6.e4" interaction="false"/><pair id="DrugDDI.d78.s6.p9" e1="DrugDDI.d78.s6.e3" e2="DrugDDI.d78.s6.e4" interaction="true"/></sentence><sentence id="DrugDDI.d78.s7" origId="s7" text="No other pharmacokinetic parameters were changed."/><sentence id="DrugDDI.d78.s8" origId="s8" text="The effect of BREVIBLOC on the duration of succinylcholine-induced neuromuscular blockade was studied in patients undergoing surgery."><entity id="DrugDDI.d78.s8.e0" origId="s8.p104" charOffset="14-23" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s8.e1" origId="s8.p106" charOffset="43-58" type="drug" text="succinylcholine"/><pair id="DrugDDI.d78.s8.p0" e1="DrugDDI.d78.s8.e0" e2="DrugDDI.d78.s8.e1" interaction="false"/></sentence><sentence id="DrugDDI.d78.s9" origId="s9" text="The onset of neuromuscular blockade by succinylcholine was unaffected by BREVIBLOC, but the duration of neuromuscular blockade was prolonged from 5 minutes to 8 minutes."><entity id="DrugDDI.d78.s9.e0" origId="s9.p112" charOffset="39-54" type="drug" text="succinylcholine"/><entity id="DrugDDI.d78.s9.e1" origId="s9.p115" charOffset="73-82" type="drug" text="BREVIBLOC"/><pair id="DrugDDI.d78.s9.p0" e1="DrugDDI.d78.s9.e0" e2="DrugDDI.d78.s9.e1" interaction="true"/></sentence><sentence id="DrugDDI.d78.s10" origId="s10" text="Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin."><entity id="DrugDDI.d78.s10.e0" origId="s10.p133" charOffset="102-111" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s10.e1" origId="s10.p142" charOffset="188-195" type="drug" text="digoxin"/><entity id="DrugDDI.d78.s10.e2" origId="s10.p143" charOffset="197-205" type="drug" text="morphine"/><entity id="DrugDDI.d78.s10.e3" origId="s10.p144" charOffset="207-222" type="drug" text="succinylcholine"/><entity id="DrugDDI.d78.s10.e4" origId="s10.p146" charOffset="226-234" type="drug" text="warfarin"/><pair id="DrugDDI.d78.s10.p0" e1="DrugDDI.d78.s10.e0" e2="DrugDDI.d78.s10.e1" interaction="true"/><pair id="DrugDDI.d78.s10.p1" e1="DrugDDI.d78.s10.e0" e2="DrugDDI.d78.s10.e2" interaction="false"/><pair id="DrugDDI.d78.s10.p2" e1="DrugDDI.d78.s10.e0" e2="DrugDDI.d78.s10.e3" interaction="true"/><pair id="DrugDDI.d78.s10.p3" e1="DrugDDI.d78.s10.e0" e2="DrugDDI.d78.s10.e4" interaction="true"/><pair id="DrugDDI.d78.s10.p4" e1="DrugDDI.d78.s10.e1" e2="DrugDDI.d78.s10.e2" interaction="false"/><pair id="DrugDDI.d78.s10.p5" e1="DrugDDI.d78.s10.e1" e2="DrugDDI.d78.s10.e3" interaction="false"/><pair id="DrugDDI.d78.s10.p6" e1="DrugDDI.d78.s10.e1" e2="DrugDDI.d78.s10.e4" interaction="false"/><pair id="DrugDDI.d78.s10.p7" e1="DrugDDI.d78.s10.e2" e2="DrugDDI.d78.s10.e3" interaction="false"/><pair id="DrugDDI.d78.s10.p8" e1="DrugDDI.d78.s10.e2" e2="DrugDDI.d78.s10.e4" interaction="false"/><pair id="DrugDDI.d78.s10.p9" e1="DrugDDI.d78.s10.e3" e2="DrugDDI.d78.s10.e4" interaction="false"/></sentence><sentence id="DrugDDI.d78.s11" origId="s11" text="While taking beta blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic."><entity id="DrugDDI.d78.s11.e0" origId="s11.p148" charOffset="13-26" type="drug" text="beta blockers"/></sentence><sentence id="DrugDDI.d78.s12" origId="s12" text="Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction."><entity id="DrugDDI.d78.s12.e0" origId="s12.p167" charOffset="56-67" type="drug" text="epinephrine"/></sentence><sentence id="DrugDDI.d78.s13" origId="s13" text="Caution should be exercised when considering the use of BREVIBLOC and verapamil in patients with depressed myocardial function."><entity id="DrugDDI.d78.s13.e0" origId="s13.p179" charOffset="56-65" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s13.e1" origId="s13.p181" charOffset="70-79" type="drug" text="verapamil"/><pair id="DrugDDI.d78.s13.p0" e1="DrugDDI.d78.s13.e0" e2="DrugDDI.d78.s13.e1" interaction="true"/></sentence><sentence id="DrugDDI.d78.s14" origId="s14" text="Fatal cardiac arrests have occurred in patients receiving both drugs."><entity id="DrugDDI.d78.s14.e0" origId="s14.p190" charOffset="63-68" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d78.s15" origId="s15" text="Additionally, BREVIBLOC should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine, epinephrine, and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high."><entity id="DrugDDI.d78.s15.e0" origId="s15.p192" charOffset="14-23" type="drug" text="BREVIBLOC"/><entity id="DrugDDI.d78.s15.e1" origId="s15.p207" charOffset="158-166" type="drug" text="dopamine"/><entity id="DrugDDI.d78.s15.e2" origId="s15.p208" charOffset="168-179" type="drug" text="epinephrine"/><entity id="DrugDDI.d78.s15.e3" origId="s15.p210" charOffset="185-199" type="drug" text="norepinephrine"/><pair id="DrugDDI.d78.s15.p0" e1="DrugDDI.d78.s15.e0" e2="DrugDDI.d78.s15.e1" interaction="true"/><pair id="DrugDDI.d78.s15.p1" e1="DrugDDI.d78.s15.e0" e2="DrugDDI.d78.s15.e2" interaction="true"/><pair id="DrugDDI.d78.s15.p2" e1="DrugDDI.d78.s15.e0" e2="DrugDDI.d78.s15.e3" interaction="true"/><pair id="DrugDDI.d78.s15.p3" e1="DrugDDI.d78.s15.e1" e2="DrugDDI.d78.s15.e2" interaction="false"/><pair id="DrugDDI.d78.s15.p4" e1="DrugDDI.d78.s15.e1" e2="DrugDDI.d78.s15.e3" interaction="false"/><pair id="DrugDDI.d78.s15.p5" e1="DrugDDI.d78.s15.e2" e2="DrugDDI.d78.s15.e3" interaction="false"/></sentence></document>